PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, College of Medicine.\', \'Department of Mechanical and Aerospace Engineering, Herbert Wertheim College of Engineering.\', \'Department of Environmental and Global Health, College of Public Health and Health Professions, and Emerging Pathogens Institute; and.\', \'Division of Cardiothoracic Surgery, College of Medicine, University of Florida, Gainesville, Florida, USA.\', \'Department of Biomedical Engineering, College of Science and Engineering, University of Minnesota, Minneapolis, Minnesota, USA.\', \'Department of Drug Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1172/jci.insight.148003e148003
?:hasPublicationType
?:journal
  • JCI insight
is ?:pmid of
?:pmid
?:pmid
  • 34357881
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Ex vivo SARS-CoV-2 infection of human lung reveals heterogeneous host defense and therapeutic responses.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all